ZYNE - Zynerba Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ZYNE is currently covered by 2 analysts with an average price target of $6.73. This is a potential upside of $5.43 (417.69%) from yesterday's end of day stock price of $1.3.

Zynerba Pharmaceuticals's activity chart (see below) currently has 48 price targets and 43 ratings on display. The stock rating distribution of ZYNE is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.02% with an average time for these price targets to be met of 103.5 days.

Highest price target for ZYNE is $1.11, Lowest price target is $1.11, average price target is $6.73.

Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 16-Aug-2023. First documented stock forecast 31-Aug-2015.

Currently out of the existing stock ratings of ZYNE, 2 are a BUY (50%), 2 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1.11

$-0.19 (-14.62%)

6 months 12 days ago

0/6 (0%)

$-0.18 (-13.95%)

Hold

16

6 months 13 days ago

0/2 (0%)

$3.93 (32.56%)

Buy

8

$6.7 (515.38%)

8

2 years 9 months 22 days ago

2/7 (28.57%)

$3.99 (99.50%)

113

Buy

7.25

$5.95 (457.69%)

11

2 years 11 months 18 days ago

0/4 (0%)

$2.91 (67.05%)

Buy

3 years 7 months 27 days ago

0/1 (0%)

$9.43 (110.04%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ZYNE (Zynerba Pharmaceuticals) average time for price targets to be met?

On average it took 103.5 days on average for the stock forecasts to be realized with a an average price target met ratio 13.02

Which analyst has the current highest performing score on ZYNE (Zynerba Pharmaceuticals) with a proven track record?

MICHAEL HIGGINS

Which analyst has the most public recommendations on ZYNE (Zynerba Pharmaceuticals)?

Michael Higgins works at LADENBURG and has 6 price targets and 4 ratings on ZYNE

Which analyst is the currently most bullish on ZYNE (Zynerba Pharmaceuticals)?

Lauren Chung with highest potential upside - $30.7

Which analyst is the currently most reserved on ZYNE (Zynerba Pharmaceuticals)?

Sumant Kulkarni with lowest potential downside - -$0.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?